Total Payments
$192,170
2021 Payments
$66.22
Companies
7
Transactions
277
Medicare Patients
806
Medicare Billing
$21,495
Payment Breakdown by Category
Other$152,297 (79.3%)
Travel$21,104 (11.0%)
Consulting$12,556 (6.5%)
Food & Beverage$6,200 (3.2%)
Education$12.19 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $152,297 | 66 | 79.3% |
| Travel and Lodging | $21,104 | 90 | 11.0% |
| Consulting Fee | $12,556 | 11 | 6.5% |
| Food and Beverage | $6,200 | 108 | 3.2% |
| Education | $12.19 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $66,582 | 80 | $0 (2021) |
| PFIZER INC. | $53,793 | 97 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38,616 | 58 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $18,770 | 22 | $0 (2019) |
| Lilly USA, LLC | $13,126 | 14 | $0 (2020) |
| Boston Scientific Corporation | $1,270 | 5 | $0 (2018) |
| Lantheus Medical Imaging, Inc. | $12.01 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $66.22 | 2 | Novartis Pharmaceuticals Corporation ($43.94) |
| 2020 | $5,012 | 9 | Lilly USA, LLC ($4,058) |
| 2019 | $16,512 | 34 | Lilly USA, LLC ($7,262) |
| 2018 | $53,563 | 71 | Novartis Pharmaceuticals Corporation ($23,927) |
| 2017 | $117,017 | 161 | PFIZER INC. ($41,345) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/12/2021 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $43.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2020 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.91 | General |
| 03/12/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,037.50 | General |
| Category: Diabetes | ||||||
| 03/12/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Diabetes | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $478.11 | General |
| Category: DIABETES | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $173.38 | General |
| Category: DIABETES | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $145.00 | General |
| Category: DIABETES | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $60.89 | General |
| Category: DIABETES | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $51.42 | General |
| Category: DIABETES | ||||||
| 03/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: DIABETES | ||||||
| 11/12/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Diabetes | ||||||
| 11/12/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Diabetes | ||||||
| 11/07/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $150.80 | General |
| Category: Diabetes | ||||||
| 11/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $61.81 | General |
| Category: DIABETES | ||||||
| 10/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,675.00 | General |
| Category: DIABETES | ||||||
| 10/30/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $10.44 | General |
| Category: DIABETES | ||||||
| 10/28/2019 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $173.39 | General |
| 10/28/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 10/16/2019 | Lilly USA, LLC | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Diabetes | ||||||
| 10/16/2019 | Lantheus Medical Imaging, Inc. | Definity (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Contrast Agent | ||||||
| 10/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: DIABETES | ||||||
| 10/09/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: DIABETES | ||||||
| 09/20/2019 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $676.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 36 | 40 | $4,864 | $1,429 |
| 2021 | 5 | 572 | 693 | $38,296 | $11,803 |
| 2020 | 3 | 198 | 226 | $26,626 | $8,263 |
Total Patients
806
Total Services
959
Medicare Billing
$21,495
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 24 | 24 | $4,512 | $1,324 | 29.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 12 | 16 | $352.00 | $104.64 | 29.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 93 | 93 | $17,484 | $4,969 | 28.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 382 | 494 | $10,868 | $3,205 | 29.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 36 | 36 | $6,768 | $2,007 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 12 | $1,608 | $884.82 | 55.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 14 | $756.00 | $501.32 | 66.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 27 | 32 | $704.00 | $205.53 | 29.2% |
| 93325 | Doppler ultrasound study of color-directed heart blood flow, rate, and valve function | Facility | 2021 | 11 | 12 | $108.00 | $30.12 | 27.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 66 | 66 | $12,408 | $3,931 | 31.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 61 | 61 | $11,468 | $3,499 | 30.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 58 | 86 | $1,892 | $580.50 | 30.7% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 13 | 13 | $858.00 | $251.58 | 29.3% |
About Dr. Paul Fenster, MD
Dr. Paul Fenster, MD is a Cardiovascular Disease healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285646497.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Fenster, MD has received a total of $192,170 in payments from pharmaceutical and medical device companies, with $66.22 received in 2021. These payments were reported across 277 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($152,297).
As a Medicare-enrolled provider, Fenster has provided services to 806 Medicare beneficiaries, totaling 959 services with total Medicare billing of $21,495. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Tucson, AZ
- Active Since 08/13/2006
- Last Updated 05/16/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1285646497
Products in Payments
- ELIQUIS (Drug) $66,870
- JARDIANCE (Drug) $51,454
- ENTRESTO (Drug) $50,651
- GILENYA (Drug) $15,868
- WATCHMAN (Device) $1,270
- VYNDAQEL (Drug) $122.76
- PRADAXA (Drug) $110.35
- LEQVIO (Drug) $43.94
- Definity (Drug) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tucson
Thomas Waggoner, D.o, D.O
Cardiovascular Disease — Payments: $543,824
Cardiovascular Disease $543,824
Marvin Slepian, Md, MD
Cardiovascular Disease — Payments: $280,127
Cardiovascular Disease $280,127
Karl Kern, Md, MD
Cardiovascular Disease — Payments: $167,139
Cardiovascular Disease $167,139
Dr. Stephen Algeo, Md, MD
Cardiovascular Disease — Payments: $111,127
Cardiovascular Disease $111,127
Kartik Reddy, Md, MD
Cardiovascular Disease — Payments: $81,896
Cardiovascular Disease $81,896
Mark Goldberg, M.d, M.D
Cardiovascular Disease — Payments: $70,960
Cardiovascular Disease $70,960